Protagonist Therapeutics Inc (PTGX)
46.76
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
46.80
+0.04
(+0.09%)
After-Hours: 20:00
Protagonist Therapeutics Total Assets (Quarterly): 614.63M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 614.63M |
| March 31, 2024 | 629.28M |
| December 31, 2023 | 357.95M |
| September 30, 2023 | 330.02M |
| June 30, 2023 | 320.47M |
| March 31, 2023 | 239.86M |
| December 31, 2022 | 247.93M |
| September 30, 2022 | 282.17M |
| June 30, 2022 | 310.51M |
| March 31, 2022 | 348.30M |
| December 31, 2021 | 347.70M |
| September 30, 2021 | 373.18M |
| June 30, 2021 | 404.23M |
| March 31, 2021 | 298.07M |
| December 31, 2020 | 324.47M |
| September 30, 2020 | 217.32M |
| June 30, 2020 | 224.98M |
| March 31, 2020 | 134.90M |
| Date | Value |
|---|---|
| December 31, 2019 | 154.92M |
| September 30, 2019 | 154.63M |
| June 30, 2019 | 148.10M |
| March 31, 2019 | 132.25M |
| December 31, 2018 | 139.47M |
| September 30, 2018 | 148.86M |
| June 30, 2018 | 137.47M |
| March 31, 2018 | 149.24M |
| December 31, 2017 | 163.73M |
| September 30, 2017 | 110.42M |
| June 30, 2017 | 70.48M |
| March 31, 2017 | 82.67M |
| December 31, 2016 | 93.99M |
| September 30, 2016 | 102.84M |
| June 30, 2016 | 24.52M |
| March 31, 2016 | 31.86M |
| December 31, 2015 | 14.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
134.90M
Minimum
Mar 2020
629.28M
Maximum
Mar 2024
324.26M
Average
320.47M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 178.29B |
| Assembly Biosciences Inc | 115.32M |
| Precision BioSciences Inc | 165.80M |
| Entrada Therapeutics Inc | 581.96M |
| NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 73.30M |
| Shareholders Equity (Quarterly) | 541.32M |
| Current Ratio | 13.73 |